Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


4 Antiviral Res
12 BMJ
2 Cell
6 Epidemiol Infect
1 J Gen Virol
2 J Infect
1 J Infect Dis
1 J Virol
7 J Virol Methods
7 Lancet
2 MMWR Morb Mortal Wkly Rep
5 N Engl J Med
1 PLoS Comput Biol
25 PLoS One
4 Proc Natl Acad Sci U S A
9 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antiviral Res

  1. KASPRZYK R, Spiewla TJ, Smietanski M, Golojuch S, et al
    Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase.
    Antiviral Res. 2021;193:105142.
    PubMed         Abstract available

  2. TOURET F, Driouich JS, Cochin M, Petit PR, et al
    Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.
    Antiviral Res. 2021;193:105137.
    PubMed         Abstract available

  3. GAN ES, Syenina A, Linster M, Ng B, et al
    A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection.
    Antiviral Res. 2021;193:105138.
    PubMed         Abstract available

  4. PERSOONS L, Vanderlinden E, Vangeel L, Wang X, et al
    Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
    Antiviral Res. 2021 Jul 1:105127. doi: 10.1016/j.antiviral.2021.105127.
    PubMed         Abstract available


  5. GEORGE G, Srivastava A, Melvin H, Okwu U, et al
    Teaching Careers Clinic.
    BMJ. 2021;374:n1385.

  6. CHUNG A, Tully L, Czernin S, Thompson R, et al
    Reducing risk of childhood obesity in the wake of covid-19.
    BMJ. 2021;374:n1716.

  7. PARKER M, Bedford H, Ussher M, Stead M, et al
    Should covid vaccination be mandatory for health and care staff?
    BMJ. 2021;374:n1903.

    Patient commentary: Protect patients like me-make covid vaccines mandatory for all eligible staff in care settings.
    BMJ. 2021;374:n1921.

  9. AHMED N
    Commentary: Mandatory covid vaccination blames individual care home workers for government failures.
    BMJ. 2021;374:n1902.

  10. SHEMTOB L, Ferris M, Asanati K, Majeed A, et al
    Vaccinating healthcare workers against covid-19.
    BMJ. 2021;374:n1975.

  11. MAJEED A
    Longitudinal data on covid-19 immunity could be collected from medical records.
    BMJ. 2021;374:n1976.

  12. BANNON C
    Covid-19 laboratory leak hypothesis: a convenient scapegoat.
    BMJ. 2021;374:n2010.

    Covid-19 laboratory leak hypothesis: extraordinary claims demand extraordinary evidence.
    BMJ. 2021;374:n2006.

  14. SHIN GY, Manuel R
    Covid-19 laboratory leak hypothesis: how a few kept the many from considering alternative possibilities.
    BMJ. 2021;374:n2003.

  15. NABAVI N
    Wellbeing at medical school: feeling prepared.
    BMJ. 2021;374:n1889.

    GPs need awareness about post-covid ME/CFS.
    BMJ. 2021;374:n1995.


  17. LIU C, Ginn HM, Dejnirattisai W, Supasa P, et al
    Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
    Cell. 2021;184:4220-4236.
    PubMed         Abstract available

  18. LI D, Edwards RJ, Manne K, Martinez DR, et al
    In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
    Cell. 2021;184:4203-4219.
    PubMed         Abstract available

    Epidemiol Infect

  19. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    PubMed         Abstract available

  20. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    PubMed         Abstract available

  21. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    PubMed         Abstract available

  22. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    PubMed         Abstract available

  23. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    PubMed         Abstract available

  24. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    PubMed         Abstract available

    J Gen Virol

  25. HIRST JC, Hutchinson EC
    Corrigendum: Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2021;102.

    J Infect

  26. MOSELEY E, Williams P, Muir P, Marlow R, et al
    Influenza A/B and respiratory syncytial virus digital immunoassay evaluation in a paediatric emergency department.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00397.

  27. GAO R, Zheng H, Liu K, Ji Z, et al
    Genesis, Evolution and Host Species Distribution of influenza A (H10N3) Virus in China.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00403.

    J Infect Dis

  28. LINNIK J, Syedbasha M, Kaltenbach HM, Vogt D, et al
    Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant (HSCT) patients.
    J Infect Dis. 2021 Aug 20. pii: 6355382. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  29. SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
    TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
    J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
    PubMed         Abstract available

    J Virol Methods

  30. KIM YK, Chang SH
    Clinical usefulness of extraction-free PCR assay to detect SARS-CoV-2.
    J Virol Methods. 2021;296:114217.
    PubMed         Abstract available

  31. JAGTAP S, K R, Valloly P, Sharma R, et al
    Evaluation of spike protein antigens for SARS-CoV-2 serology.
    J Virol Methods. 2021;296:114222.
    PubMed         Abstract available

  32. LAU CS, Hoo SP, Koh JMJ, Phua SK, et al
    Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.
    J Virol Methods. 2021;296:114224.
    PubMed         Abstract available

  33. SHELITE TR, Uscanga-Palomeque AC, Castellanos-Gonzalez A, Melby PC, et al
    Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.
    J Virol Methods. 2021;296:114227.
    PubMed         Abstract available

  34. RAMOS A, Cardoso MJ, Norton P, Sarmento A, et al
    Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.
    J Virol Methods. 2021;296:114223.
    PubMed         Abstract available

  35. DE OLIVEIRA CM, Brochi L, Scarpelli LC, Lopes ACW, et al
    SARS-CoV-2 saliva testing is a useful tool for Covid-19 diagnosis.
    J Virol Methods. 2021;296:114241.
    PubMed         Abstract available

  36. CHAINTOUTIS SC, Chassalevris T, Tsiolas G, Balaska S, et al
    A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions.
    J Virol Methods. 2021;296:114242.
    PubMed         Abstract available


  37. SHANKAR-HARI M, Vale CL, Godolphin PJ, Fisher D, et al
    Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
    JAMA. 2021 Jul 6. pii: 2781880. doi: 10.1001/jama.2021.11330.
    PubMed         Abstract available

  38. OLDENBURG CE, Pinsky BA, Brogdon J, Chen C, et al
    Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.
    JAMA. 2021 Jul 16. pii: 2782166. doi: 10.1001/jama.2021.11517.
    PubMed         Abstract available

    A Pandemic of Lights.
    JAMA. 2021;326:481-482.

  40. ABBASI J
    Antigen Testing Every 3 Days Is Highly Sensitive for SARS-CoV-2.
    JAMA. 2021;326:473.

  41. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.

  42. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.


  43. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    PubMed         Abstract available

  44. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    PubMed         Abstract available

  45. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.

  46. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.

  47. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    PubMed         Abstract available

  48. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.

  49. IJSSELMUIDEN C, Ntoumi F, Lavery JV, Montoya J, et al
    Should global financing be the main priority for pandemic preparedness?
    Lancet. 2021;398:388.

    MMWR Morb Mortal Wkly Rep

  50. HODGES E, Lefferts B, Bates E, Desnoyers C, et al
    Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities - Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1120-1123.
    PubMed         Abstract available

  51. ROSSEN LM, Ahmad FB, Anderson RN, Branum AM, et al
    Disparities in Excess Mortality Associated with COVID-19 - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1114-1119.
    PubMed         Abstract available

    N Engl J Med

  52. KAMAR N, Abravanel F, Marion O, Couat C, et al
    Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.

  53. EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
    Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.

  54. LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
    PubMed         Abstract available

  55. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 1.
    N Engl J Med. 2021;385:e24.

  56. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 2.
    N Engl J Med. 2021;385:e25.

    PLoS Comput Biol

  57. PREM K, Zandvoort KV, Klepac P, Eggo RM, et al
    Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era.
    PLoS Comput Biol. 2021;17:e1009098.
    PubMed         Abstract available

    PLoS One

  58. SUAREZ-GARCIA I, Perales-Fraile I, Gonzalez-Garcia A, Munoz-Blanco A, et al
    In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain.
    PLoS One. 2021;16:e0255524.
    PubMed         Abstract available

  59. JIANG D, Chen J, Liu Y, Lin J, et al
    Patterns of mental health problems before and after easing COVID-19 restrictions: Evidence from a 105248-subject survey in general population in China.
    PLoS One. 2021;16:e0255251.
    PubMed         Abstract available

  60. NWOSU CO
    Childcare and depression during the coronavirus pandemic in South Africa: A gendered analysis.
    PLoS One. 2021;16:e0255183.
    PubMed         Abstract available

  61. LAFTA R, Qusay N, Mary M, Burnham G, et al
    Violence against doctors in Iraq during the time of COVID-19.
    PLoS One. 2021;16:e0254401.
    PubMed         Abstract available

  62. RIUTORD-SBERT P, Pereira TC, de Pedro-Gomez JE, Gonzalez-Carrasco D, et al
    Study of the use of a personalized peripheral sealing device on surgical face masks in high-risk situations against COVID-19.
    PLoS One. 2021;16:e0253382.
    PubMed         Abstract available

  63. OSPINA J, Jiang T, Hoying K, Crocker J, et al
    Compassionate goals predict COVID-19 health behaviors during the SARS-CoV-2 pandemic.
    PLoS One. 2021;16:e0255592.
    PubMed         Abstract available

  64. ENDRIYAS M, Kawza A, Alano A, Hussen M, et al
    Knowledge and attitude towards COVID-19 and its prevention in selected ten towns of SNNP Region, Ethiopia: Cross-sectional survey.
    PLoS One. 2021;16:e0255884.
    PubMed         Abstract available

  65. SPITZER MWH, Musslick S
    Academic performance of K-12 students in an online-learning environment for mathematics increased during the shutdown of schools in wake of the COVID-19 pandemic.
    PLoS One. 2021;16:e0255629.
    PubMed         Abstract available

  66. KOWALL B, Standl F, Oesterling F, Brune B, et al
    Excess mortality due to Covid-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden and Spain.
    PLoS One. 2021;16:e0255540.
    PubMed         Abstract available

  67. ALQAHTANI JS, Oyelade T, Aldhahir AM, Mendes RG, et al
    Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0255659.
    PubMed         Abstract available

  68. TIELKER JM, Weber JP, Simon ST, Bausewein C, et al
    Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany.
    PLoS One. 2021;16:e0254056.
    PubMed         Abstract available

  69. KARIMI SM, Salunkhe SS, White KB, Little BB, et al
    Prevalence of unmasked and improperly masked behavior in indoor public areas during the COVID-19 pandemic: Analysis of a stratified random sample from Louisville, Kentucky.
    PLoS One. 2021;16:e0248324.
    PubMed         Abstract available

  70. BRIGGS N, Gormally MV, Li F, Browning SL, et al
    Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19.
    PLoS One. 2021;16:e0254453.
    PubMed         Abstract available

  71. REQUIAO-MOURA LR, Sandes-Freitas TV, Viana LA, Cristelli MP, et al
    High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study.
    PLoS One. 2021;16:e0254822.
    PubMed         Abstract available

  72. GUO X, Tong J, Chen P, Fan W, et al
    The suppression effect of emotional contagion in the COVID-19 pandemic: A multi-layer hybrid modelling and simulation approach.
    PLoS One. 2021;16:e0253579.
    PubMed         Abstract available

  73. LEON-ABARCA JA, Portmann-Baracco A, Bryce-Alberti M, Ruiz-Sanchez C, et al
    Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients.
    PLoS One. 2021;16:e0255144.
    PubMed         Abstract available

  74. CHINNA K, Sundarasen S, Khoshaim HB, Kamaludin K, et al
    Psychological impact of COVID-19 and lock down measures: An online cross-sectional multicounty study on Asian university students.
    PLoS One. 2021;16:e0253059.
    PubMed         Abstract available

  75. MANT M, Aslemand A, Prine A, Jaagumagi Holland A, et al
    University students' perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study.
    PLoS One. 2021;16:e0255447.
    PubMed         Abstract available

  76. NATNAEL T, Adane M, Alemnew Y, Andualem A, et al
    COVID-19 knowledge, attitude and frequent hand hygiene practices among taxi drivers and associated factors in urban areas of Ethiopia.
    PLoS One. 2021;16:e0253452.
    PubMed         Abstract available

  77. AHMED MS, Aurpa TT, Anwar MM
    Detecting sentiment dynamics and clusters of Twitter users for trending topics in COVID-19 pandemic.
    PLoS One. 2021;16:e0253300.
    PubMed         Abstract available

  78. AHARON DY, Jacobi A, Cohen E, Tzur J, et al
    COVID-19, government measures and hospitality industry performance.
    PLoS One. 2021;16:e0255819.
    PubMed         Abstract available

  79. KAWAMOTO M, Tanaka H, Sakurai A, Otagiri H, et al
    Exploration of correlation of oral hygiene and condition with influenza infection.
    PLoS One. 2021;16:e0254981.
    PubMed         Abstract available

  80. ZHAO X, Tatapudi H, Corey G, Gopalappa C, et al
    Threshold analyses on combinations of testing, population size, and vaccine coverage for COVID-19 control in a university setting.
    PLoS One. 2021;16:e0255864.
    PubMed         Abstract available

  81. QI S, Hua F, Xu S, Zhou Z, et al
    Trends of global health literacy research (1995-2020): Analysis of mapping knowledge domains based on citation data mining.
    PLoS One. 2021;16:e0254988.
    PubMed         Abstract available

  82. MUKERJEE S, Chow CM, Li M
    Mitigation strategies and compliance in the COVID-19 fight; how much compliance is enough?
    PLoS One. 2021;16:e0239352.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  83. XING X, Xiong Y, Yang R, Wang R, et al
    Predicting the effect of confinement on the COVID-19 spread using machine learning enriched with satellite air pollution observations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  84. SAH P, Fitzpatrick MC, Zimmer CF, Abdollahi E, et al
    Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  85. BETSCH C, Sprengholz P, Siegers R, Eitze S, et al
    Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  86. FETZER T, Graeber T
    Measuring the scientific effectiveness of contact tracing: Evidence from a natural experiment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  87. RAJAN S, Akhtar N, Sharma S, Chakrabarti D, et al
    COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00956.

  88. TISSOT N, Brunel AS, Bozon F, Rosolen B, et al
    Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine.
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00925.
    PubMed         Abstract available

  89. TEASDALE CA, Borrell LN, Shen Y, Kimball S, et al
    Parental plans to vaccinate children for COVID-19 in New York city.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00949.
    PubMed         Abstract available

  90. PALLADINO G, Ferrari A, Music N, Settembre EC, et al
    Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
    PubMed         Abstract available

  91. STINSON JA, Boopathy AV, Cieslewicz BM, Zhang Y, et al
    Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)00957.
    PubMed         Abstract available

  92. HAYMAN B, Dennehy M
    Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00922.
    PubMed         Abstract available

  93. BURKE PF, Masters D, Massey G
    Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00947.
    PubMed         Abstract available

  94. KONTOPOULOU K, Ainatzoglou A, Nakas CT, Ifantidou A, et al
    Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00958.
    PubMed         Abstract available

  95. PIERCE-RUIZ C, Santana WI, Sutton WJH, Fischler DA, et al
    Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.
    Vaccine. 2021;39:5106-5115.
    PubMed         Abstract available

    Virus Res

  96. BURNHAM AJ, Miller JR, Singh I, Billings EA, et al
    Novel isoforms of influenza virus PA-X and PB1-F2 indicated by automatic annotation.
    Virus Res. 2021 Aug 12:198545. doi: 10.1016/j.virusres.2021.198545.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.